ReviewPharmacogenomics and personalized medicine2015

Targeted treatment for chronic lymphocytic leukemia: clinical potential of obinutuzumab.

Lukáš SmolejPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.